5+
More Accessible, Affordable
Biologics for Humanity
Application
Boasting unique competitiveness in key technical areas of biopharmaceutical industrialization, Thousand Oaks Biopharmaceuticals is experienced in providing full CDMO services ranging from vaccine products to recombinant protein products, and cell/gene therapeutic products.
Our Capabilities
Thousand Oaks Biopharmaceuticals, as a one-stop biopharmaceutical CDMO, enables its partners to deliver accessible and affordable biologics!
Achievements
Thousand Oaks Biopharmaceuticals (Nantong) has been ISO certified, and is among the early macromolecule CDMO granted with the drug manufacturing license in China.
-
BLA Projects -
Molecules at clinical30+
-
CCM manufacturing capacity1000ton+
-
cGMP manufacturing capacity20000L
Latest News
-
Clover Biopharma cooperates with Thousand Oaks Biopharmaceuticals Co., Ltd. to accelerate industrialization of COVID-19 subunit vaccine candidate "S-Trimer”2020-11-13 -
Congratulations! Thousand Oaks Biopharmaceuticals Co., Ltd. completes first batch of samples for Phase III clinical trial of Gensciences2020-09-27 -
Thousand Oaks Biopharmaceuticals Co., Ltd. reaches strategic partnership with Biotheus2020-08-14 -
Thousand Oaks Biopharmaceuticals Co., Ltd. announces the signing of a RMB 450m series B financing2020-07-23 -
Win-win cooperation! JSBiosciences and Hengrui Pharma attend ceremony to sign strategic cooperation agreement2020-05-08
上一页
下一页